Eszopiclone
Generic Details
Generic Name
Eszopiclone
Other Names
- Lunesta
Drug Class
- Nonbenzodiazepine Hypnotic
Chemical Formula
C17H17ClN6O3
Molecular Weight
388.81 g/mol
Mechanism of Action
- Binds to GABA receptors at the same location as benzodiazepines, enhancing the inhibitory effects of GABA
Indications
- Treatment of insomnia characterized by difficulty falling asleep
Common Dosage Forms
- Tablet
Typical Dosage
- 1-3 mg at bedtime
Pediatric Dosage
- Not recommended for use in children under 18
Geriatric Dosage
- 1 mg at bedtime
Side Effects
- Dizziness
- Headache
- Drowsiness
- Dry mouth
- Unpleasant taste in mouth
Contraindications
- Severe respiratory insufficiency
- Severe hepatic impairment
- Co-administration with strong CYP3A4 inhibitors
Pregnancy Category
- C - Risk cannot be ruled out
Lactation Safety
- Not recommended during breastfeeding
Drug Interactions
- Alcohol
- Central nervous system depressants
- Strong CYP3A4 inhibitors
Overdose Symptoms
- Excessive drowsiness
- Mental confusion
- Slowed breathing
Antidote for Overdose
- Flumazenil (benzodiazepine receptor antagonist)
Storage Conditions
- Store at room temperature away from light and moisture
Pharmacokinetics
- Absorption: Rapidly absorbed, with a Tmax of approximately 1 hour
- Distribution: Highly protein-bound (>97%)
- Metabolism: Primarily hepatic via CYP3A4
- Excretion: Mainly renal, with minimal excretion of unchanged drug in urine
Precautions
- History of substance abuse
- Depression
- Suicidal tendencies
Warnings
- May cause complex sleep-related behaviors including sleep-driving and sleep-eating
Others
- May be habit-forming if used for an extended period